Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

The prospective cohort study, published in The Journal of Nutrition, found that consuming one or more eggs per week was ...

Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...

New tests and new treatments are presenting more options for certain patients with Alzheimer's disease. “Today a confluence ...

More than seven million Americans are living with Alzheimer’s, a disease that takes a heavy toll on families emotionally and financially.

JUST off the press this May 2025 is a revolutionary book on Alzheimer’s disease called "Alzheimer’s: Prevention Is the Cure." ...